• YTHDF1 Phase Separation Drives SSC Transdifferentiation via

  2026-05-08

  Fang et al. reveal that liquid-liquid phase separation (LLPS) of the m6A reader YTHDF1 is essential for the direct conversion of spermatogonial stem cells (SSCs) into neural stem cell-like cells. By activating the IkB-NF-kB-CCND1 axis through selective inhibition of IkBa/b mRNA translation, their findings provide mechanistic insight into how protein-RNA condensates govern cell fate transitions.

• Nuclear cGAS-TRIM41 Axis Suppresses L1 Retrotransposition vi

  2026-05-07

  This study reveals that nuclear cGAS restricts LINE-1 (L1) retrotransposition by promoting TRIM41-mediated degradation of ORF2p, a critical L1 protein, thus preserving genome stability. Crucially, Chk2-dependent phosphorylation of cGAS facilitates this process, providing new insights into posttranslational regulation of genome integrity and potential intervention points in cancer and aging.

• 2-Deoxy-D-glucose: Precision Glycolysis Inhibition in Cancer

  2026-05-07

  2-Deoxy-D-glucose (2-DG) stands at the forefront of glycolysis inhibition, empowering researchers to dissect metabolic vulnerabilities in cancer and virology. Learn how to optimize experimental design, troubleshoot metabolic assays, and integrate the latest mechanistic insights on tumor progression and cellular senescence.

• Baicalin Methyl Ester: Protocols for Intestinal Barrier Prot

  2026-05-06

  Baicalin methyl ester, an esterified derivative of baicalin, enables precise modulation of the P65/TNF-α/MLCK/ZO-1 signaling pathway, providing robust protection in models of LPS-induced intestinal barrier damage. This guide translates cutting-edge findings into actionable workflows, troubleshooting insights, and comparative advantages for anti-inflammatory and gut barrier research.

• Bafilomycin C1: Reliable V-ATPase Inhibition for Cell Assays

  2026-05-06

  This article addresses major challenges in cell viability and autophagy assays, providing scenario-driven guidance for researchers using Bafilomycin C1 (SKU C4729). It integrates evidence-based protocol advice, data-backed troubleshooting, and vendor selection insights, positioning Bafilomycin C1 as a dependable vacuolar H+-ATPases inhibitor for reproducible results.

• Disulfiram as a Dopamine β-Hydroxylase Inhibitor in Cancer R

  2026-05-05

  Disulfiram’s dual activity as a dopamine β-hydroxylase inhibitor and proteasome modulator unlocks advanced experimental strategies for apoptosis and cancer biology. This article delivers actionable workflows, troubleshooting insights, and practical integration tips for maximizing Disulfiram’s impact in translational oncology and cell-based assays.

• Oteseconazole (VT-1161): Pharmacokinetics, Selectivity, and

  2026-05-05

  Explore the unique pharmacokinetics and drug interaction profile of Oteseconazole (VT-1161), a next-generation antifungal agent. This article provides a deeper analysis of selectivity, CYP51 inhibition, and clinical implications for Candida research.

• Docetaxel in Cancer Chemotherapy Research: Protocols & Pitfa

  2026-05-04

  Docetaxel (Taxotere) offers unmatched reliability for dissecting microtubule dynamics, apoptosis induction, and chemoresistance mechanisms in cancer chemotherapy research. This guide delivers actionable workflows, troubleshooting strategies, and evidence-backed insights to ensure reproducibility and maximize the impact of APExBIO’s Docetaxel in both in vitro and in vivo models.

• ABT-737: BCL-2 Protein Inhibitor for Apoptosis in Cancer Cel

  2026-05-04

  ABT-737, a potent small molecule BCL-2 protein inhibitor from APExBIO, offers unparalleled selectivity for apoptosis induction in cancer research workflows. This article demystifies advanced protocol design, troubleshooting, and the unique insights gained from integrating recent proteasome modulation findings.

• GANT61 Triggers Apoptosis in ALK+ ALCL via Hh-PIK3IP1-Akt Mo

  2026-05-03

  This study reveals that GANT61, a Hedgehog pathway inhibitor, suppresses proliferation and induces apoptosis in ALK-positive anaplastic large cell lymphoma (ALK+ ALCL) by targeting the Hh-PIK3IP1-Akt signaling axis. The findings provide mechanistic insights into Gli1 inhibition and highlight new therapeutic strategies for ALK+ ALCL.

• Tacalcitol Monohydrate: Dual-Action Innovation for Translati

  2026-05-02

  Tacalcitol monohydrate, a synthetic analog of vitamin D3, is redefining the translational landscape in oncology and dermatology. By uniquely leveraging both VDR and CaSR pathways, Tacalcitol enables researchers to address unmet needs in combinatorial cancer therapy and neurodermatology, offering actionable strategies validated by recent mechanistic and preclinical studies.

• 3-(1-methylpyrrolidin-2-yl)pyridine (N2703): Mechanism, Evid

  2026-05-02

  3-(1-methylpyrrolidin-2-yl)pyridine (N2703) is a synthetic small molecule for biomedical research, offering high purity and broad solvent compatibility. N2703 enables precise modulation of cellular signaling pathways and is validated as an investigational tool for probing protein interactions and receptor-mediated responses. This article summarizes its mechanism, benchmarks, and integration in advanced workflows.

• Super-Resolution Imaging Reveals Mitochondrial mRNA Dynamics

  2026-05-01

  This study pioneers the use of single-molecule FISH with STED and MINFLUX super-resolution microscopy to visualize and quantify mitochondrial mRNAs in situ. The resulting insights into mRNA distribution, release during apoptosis, and spatial proximity to ribosomes offer new avenues for mitochondrial gene regulation research and disease modeling.

• YTHDF2 Suppression Enhances Memory via m6A mRNA Stabilizatio

  2026-04-30

  The referenced study reveals that conditional knockout of YTHDF2 in the mouse forebrain reduces degradation of m6A-modified mRNAs, resulting in heightened synaptic transmission and improved hippocampus-dependent memory. These findings clarify the crucial role of m6A dynamics, specifically YTHDF2-mediated mRNA decay, in regulating protein synthesis and neural plasticity, with broad implications for understanding memory formation.

• Tacalcitol Monohydrate: Synthetic Vitamin D3 Analog in Cell

  2026-04-30

  Tacalcitol monohydrate, a synthetic analog of vitamin D3, enables precise modulation of gene expression and NGF induction in keratinocytes and cancer cell lines. Its low calcemic toxicity and synergy with chemotherapeutics make it a standout reagent for translational dermatology and oncology research.

408 records 16/28 page Previous Next First page 上5页 1617181920 下5页 Last page